glp 1 training course ISSA Launches GLP-1 Support for Trainers Semaglutide & Tirzepatide CME |

The ADA now recommends GLP1 RAs with proven benefit to slow CKD progression and reduce CV risk in people with type 2 diabetes

In addition, studies in which weight loss was greater during treatment than in the control group and studies in which lifestyle interventions were continued observed significant weight gain after drug discontinuation

There is growing interest in the relationship between Alzheimers disease (AD) and diabetes mellitus (DM), and the glucagon-like peptide-1 receptor (GLP-1R) may be an important link between these two diseases

Benefits: Helps reduce stubborn fat, supports cardiovascular and immune health, promotes digestion, and contributes to long-term metabolic and weight management

Find out in this easy to follow guide for people using injectables for weight loss.

Your satisfaction is our top priority, and we're here to ensure you have a positive experience with our products